54 related articles for article (PubMed ID: 11115781)
1. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
Livingstone DE; Kenyon CJ; Walker BR
J Endocrinol; 2000 Dec; 167(3):533-9. PubMed ID: 11115781
[TBL] [Abstract][Full Text] [Related]
2. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution.
Pickavance LC; Tadayyon M; Widdowson PS; Buckingham RE; Wilding JP
Br J Pharmacol; 1999 Dec; 128(7):1570-6. PubMed ID: 10602338
[TBL] [Abstract][Full Text] [Related]
4. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.
Masuzaki H; Yamamoto H; Kenyon CJ; Elmquist JK; Morton NM; Paterson JM; Shinyama H; Sharp MG; Fleming S; Mullins JJ; Seckl JR; Flier JS
J Clin Invest; 2003 Jul; 112(1):83-90. PubMed ID: 12840062
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of thiazolidinediones on adipocyte growth and recruitment in Zucker fatty rats.
MacKellar J; Cushman SW; Periwal V
PLoS One; 2009 Dec; 4(12):e8196. PubMed ID: 20041138
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Metformin Treatment Enriches
Robeson MS; Manna K; Randolph C; Byrum S; Hakkak R
Front Microbiol; 2022; 13():834776. PubMed ID: 35432282
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits inflammatory response and endoplasmic reticulum stress to improve hypothalamic aging in obese mice.
Yang L; Lu P; Qi X; Yang Q; Liu L; Dou T; Guan Q; Yu C
iScience; 2023 Oct; 26(10):108082. PubMed ID: 37860765
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation.
Woo CY; Jang JE; Lee SE; Koh EH; Lee KU
Diabetes Metab J; 2019 Jun; 43(3):247-256. PubMed ID: 30968618
[TBL] [Abstract][Full Text] [Related]
9. 11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity.
Zou C; Li W; Pan Y; Khan ZA; Li J; Wu X; Wang Y; Deng L; Liang G; Zhao Y
Oncotarget; 2017 Nov; 8(56):96263-96275. PubMed ID: 29221204
[TBL] [Abstract][Full Text] [Related]
10. A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet.
Mammi C; Marzolla V; Armani A; Feraco A; Antelmi A; Maslak E; Chlopicki S; Cinti F; Hunt H; Fabbri A; Caprio M
Int J Obes (Lond); 2016 Jun; 40(6):964-72. PubMed ID: 26830012
[TBL] [Abstract][Full Text] [Related]
11. 11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.
Dube S; Norby BJ; Pattan V; Carter RE; Basu A; Basu R
J Clin Endocrinol Metab; 2015 Jan; 100(1):E70-6. PubMed ID: 25303491
[TBL] [Abstract][Full Text] [Related]
12. A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.
Anil TM; Dandu A; Harsha K; Singh J; Shree N; Kumar VS; Lakshmi MN; Sunil V; Harish C; Balamurali GV; Naveen Kumar BS; Gopala AS; Pratibha S; Sadasivuni M; Anup MO; Moolemath Y; Venkataranganna MV; Jagannath MR; Somesh BP
BMC Pharmacol Toxicol; 2014 Aug; 15():43. PubMed ID: 25098735
[TBL] [Abstract][Full Text] [Related]
13. Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats.
Kovačević S; Nestorov J; Matić G; Elaković I
Eur J Nutr; 2014 Sep; 53(6):1409-20. PubMed ID: 24420787
[TBL] [Abstract][Full Text] [Related]
14. Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.
Schnackenberg CG; Costell MH; Krosky DJ; Cui J; Wu CW; Hong VS; Harpel MR; Willette RN; Yue TL
Biomed Res Int; 2013; 2013():427640. PubMed ID: 23586038
[TBL] [Abstract][Full Text] [Related]
15. Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats.
Hu GX; Lin H; Lian QQ; Zhou SH; Guo J; Zhou HY; Chu Y; Ge RS
PLoS One; 2013; 8(3):e49976. PubMed ID: 23533564
[TBL] [Abstract][Full Text] [Related]
16. G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.
Czegle I; Csala M; Mandl J; Benedetti A; Karádi I; Bánhegyi G
World J Hepatol; 2012 Apr; 4(4):129-38. PubMed ID: 22567185
[TBL] [Abstract][Full Text] [Related]
17. Histomorphometric changes in the perirenal adipocytes of adrenalectomized rats treated with dexamethasone.
Ahmad F; Soelaiman IN; Ramli ES; Hooi TM; Suhaimi FH
Clinics (Sao Paulo); 2011; 66(5):849-53. PubMed ID: 21789391
[TBL] [Abstract][Full Text] [Related]
18. Enhanced glycogen metabolism in adipose tissue decreases triglyceride mobilization.
Markan KR; Jurczak MJ; Allison MB; Ye H; Sutanto MM; Cohen RN; Brady MJ
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E117-25. PubMed ID: 20424138
[TBL] [Abstract][Full Text] [Related]
19. Role of biological rhythms in gastrointestinal health and disease.
Hoogerwerf WA
Rev Endocr Metab Disord; 2009 Dec; 10(4):293-300. PubMed ID: 19798581
[TBL] [Abstract][Full Text] [Related]
20. Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.
Balachandran A; Guan H; Sellan M; van Uum S; Yang K
Endocrinology; 2008 Aug; 149(8):4069-79. PubMed ID: 18467433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
